Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02625857 |
| Title | Safety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate Cancer |
| Recruitment | Completed |
| Gender | male |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Janssen Research & Development, LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| San Francisco | California | United States | Details | |||
| Baltimore | Maryland | United States | Details | |||
| Saint Louis | Missouri | United States | Details | |||
| Nashville | Tennessee | United States | Details | |||
| Houston | Texas | United States | Details | |||
| Madison | Wisconsin | United States | Details |